Once weekly recombinant human erythropoietin treatment for cancer-induced anemia in children with acute lymphoblastic leukemia receiving maintenance chemotherapy: a randomized case-controlled study. （開啟新視窗）

Abdelrazik N, Fouda M

來源‎: Hematology 2007;12(6):533-41.

檢索‎: PubMed 17852440

DOI碼‎: 10.1080/10245330701521572

https://www.ncbi.nlm.nih.gov/pubmed/17852440 （開啟新視窗）

Epoetin alpha decreases the number of erythrocyte transfusions in patients with acute lymphoblastic leukemia, lymphoblastic lymphoma, and Burkitt leukemia/lymphoma: results of a randomized clinical trial. （開啟新視窗）

Cabanillas ME, Kantarjian H, Thomas DA, Mattiuzzi GN, Rytting ME, Bruera E, Xiao L, Bekele BN, Foudray MC, Cortes JE.

來源‎: Cancer 2012;118(3):848-55.

檢索‎: PubMed 21751205

DOI碼‎: 10.1002/cncr.26341

https://www.ncbi.nlm.nih.gov/pubmed/21751205 （開啟新視窗）

Recombinant human erythropoietin beta therapy: an effective strategy to reduce transfusion requirement in children receiving anticancer treatment. （開啟新視窗）

Corapcioglu F, Aksu G, Basar EZ, Demirel A, Oncel S, Mutlu A

來源‎: Pediatr Hematol Oncol 2008;25(6):509-21.

檢索‎: PubMed 18728970

DOI碼‎: 10.1080/08880010802235132

https://www.ncbi.nlm.nih.gov/pubmed/18728970 （開啟新視窗）

Recombinant human erythropoietin beta: the effect of weekly dosing on anemia, quality of life, and long-term outcomes in pediatric cancer patients. （開啟新視窗）

Durmaz O, Demirkaya M, Sevinir B

來源‎: Pediatr Hematol Oncol 2011;28(6):461-8.

檢索‎: PubMed 21707225

DOI碼‎: 10.3109/08880018.2011.570857

https://www.ncbi.nlm.nih.gov/pubmed/21707225 （開啟新視窗）

Epoetin alfa in patients with advanced-stage Hodgkin's lymphoma: results of the randomized placebo-controlled GHSG HD15EPO trial. （開啟新視窗）

Engert A, Josting A, Haverkamp H, Villalobos M, Lohri A, Sökler M, Zijlstra J, Sturm I, Topp MS, Rank A, Zenz T, Vogelhuber M, Nogova L, Borchmann P, Fuchs M, Flechtner HH, Diehl V.

來源‎: J Clin Oncol 2010;28(13):2239-45.

檢索‎: PubMed 20368566

DOI碼‎: 10.1200/JCO.2009.25.1835

https://www.ncbi.nlm.nih.gov/pubmed/20368566 （開啟新視窗）

Treatment patterns and outcomes in management of solid cancer patients suffering from anemia in Penang hospital. （開啟新視窗）

Hassan BA, Yusoff ZB

來源‎: Asian Pac J Cancer Prev 2011;12(6):1573-6.

檢索‎: PubMed 22126501

https://www.ncbi.nlm.nih.gov/pubmed/22126501 （開啟新視窗）

Randomized, double-blind, placebo-controlled trial of every-3-week darbepoetin alfa 300 micrograms for treatment of chemotherapy-induced anemia. （開啟新視窗）

Hernandez E, Ganly P, Charu V, Dibenedetto J, Tomita D, Lillie T, Taylor K; ARANESP 20030232 Study Group

來源‎: Curr Med Res Opin 2009;25(9):2109-20.

檢索‎: PubMed 19601709

DOI碼‎: 10.1185/03007990903084164

https://www.ncbi.nlm.nih.gov/pubmed/19601709 （開啟新視窗）

Hemoglobin response and improvements in quality of life in anemic children with cancer receiving myelosuppressive chemotherapy. （開啟新視窗）

Hinds PS, Hockenberry M, Feusner J, Hord JD, Rackoff W, Rozzouk BI

來源‎: J Support Oncol 2005;3(6 Suppl 4):10-1.

檢索‎: PubMed 16355549

https://www.ncbi.nlm.nih.gov/pubmed/16355549 （開啟新視窗）

The efficacy of recombinant human erythropoietin in treatment chemotherapy induced anemia in children diagnosed with a solid cancer. （開啟新視窗）

Hiradfar A, Banihosseinian M

來源‎: Iran J Ped Hematol Oncol 2014;4(4):151-9.

檢索‎: PubMed 25598955

https://www.ncbi.nlm.nih.gov/pubmed/25598955 （開啟新視窗）

2007 Standards, Options, and Recommendations: use of erythropoiesis-stimulating agents (ESA: epoetin alfa, epoetin beta, and darbepoetin) for the management of anemia in children with cancer. （開啟新視窗）

Marec-Berard P, Chastagner P, Kassab-Chahmi D, Casadevall N, Marchal C, Misset JL, Ray-Coquard I.

來源‎: Pediatr Blood Cancer 2009;53(1):7-12.

檢索‎: PubMed 19229970

DOI碼‎: 10.1002/pbc.21953

https://www.ncbi.nlm.nih.gov/pubmed/19229970 （開啟新視窗）

Prospective study of erythropoietin use on quality of life and cost effectiveness in acute myeloid leukemia and allogeneic hematopoietic stem cell transplantation patients. （開啟新視窗）

Michallet M, Goldet K, Sobh M, Morisset S, Chelghoum Y, Thomas X, Barraco F, Ducastelle S, Labussière H, Renzullo C, Paillet C, Pivot C, Straaten PB, Denis A, Termoz A, Detrait M, Nicolini FE, Jaisson-Hot I.

來源‎: Cancer 2013;119(1):107-14.

檢索‎: PubMed 22744794

DOI碼‎: 10.1002/cncr.27686

https://www.ncbi.nlm.nih.gov/pubmed/22744794 （開啟新視窗）

Erythropoietic growth factors for children with cancer: a systematic review of the literature. （開啟新視窗）

Mystakidou K, Potamianou A, Tsilika E

來源‎: Curr Med Res Opin 2007;23(11):2841-7.

檢索‎: PubMed 17910805

DOI碼‎: 10.1185/030079907x242601

https://www.ncbi.nlm.nih.gov/pubmed/17910805 （開啟新視窗）

Double-blind, placebo-controlled study of quality of life, hematologic end points, and safety of weekly epoetin alfa in children with cancer receiving myelosuppressive chemotherapy. （開啟新視窗）

Razzouk BI, Hord JD, Hockenberry M, Hinds PS, Feusner J, Williams D, Rackoff WR

來源‎: J Clin Oncol 2006;24(22):3583-9.

檢索‎: PubMed 16877725

DOI碼‎: 10.1200/JCO.2005.03.4371

https://www.ncbi.nlm.nih.gov/pubmed/16877725 （開啟新視窗）

The role of recombinant erythropoietin in childhood cancer. （開啟新視窗）

Shankar AG

來源‎: Oncologist 2008;13(2):157-66.

檢索‎: PubMed 18305061

DOI碼‎: 10.1634/theoncologist.2007-0126

https://www.ncbi.nlm.nih.gov/pubmed/18305061 （開啟新視窗）

Efficacy and safety of iorEPOCIM for chemotherapy- or radiotherapy-induced anemia in pediatric cancer patients. （開啟新視窗）

Vargas A, Mendoza I, Uranga R, González A, Martínez L, Caballero I, Piedra P, Saurez G, Verdecia M, Cabanas R

來源‎: MEDICC Rev 2010;12(3):27-31.

檢索‎: PubMed 20697335

DOI碼‎: 10.37757/MR2010.V12.N3.7

https://www.ncbi.nlm.nih.gov/pubmed/20697335 （開啟新視窗）

A single institutional experience: is epoetin alpha effective in anemic children with cancer? （開啟新視窗）

Yilmaz D, Cetingül N, Kantar M, Oniz H, Kansoy S, Kavakli K

來源‎: Pediatr Hematol Oncol 2004;21(1):1-8.

檢索‎: PubMed 14660300

https://www.ncbi.nlm.nih.gov/pubmed/14660300 （開啟新視窗）

Single dose darbepoetin alfa is useful in reducing red cell transfusions in leukemic children receiving chemotherapy. （開啟新視窗）

Zachariah M, Elshinawy M, Alrawas A, Bashir W, Elbeshlawi I, Tony S, Wali Y

來源‎: Pediatr Hematol Oncol 2014;31(5):442-7.

檢索‎: PubMed 24088186

DOI碼‎: 10.3109/08880018.2013.824527

https://www.ncbi.nlm.nih.gov/pubmed/24088186 （開啟新視窗）

Early epoetin alfa treatment in children with solid tumors. （開啟新視窗）

Zoubek A, Kronberger M

來源‎: Med Pediatr Oncol 2002;39(4):459-62.

檢索‎: PubMed 12203664

DOI碼‎: 10.1002/mpo.10186

https://www.ncbi.nlm.nih.gov/pubmed/12203664 （開啟新視窗）

Intravenous iron sucrose for children with iron deficiency failing to respond to oral iron therapy. （開啟新視窗）

Crary SE, Hall K, Buchanan GR.

來源‎: Pediatr Blood Cancer 2011;56(4):615-9.

檢索‎: PubMed 21298748

DOI碼‎: 10.1002/pbc.22930

https://www.ncbi.nlm.nih.gov/pubmed/21298748 （開啟新視窗）

Intravenous iron sucrose for children with iron deficiency anemia. （開啟新視窗）

Kaneva K, Chow E, Rosenfield CG, Kelly MJ

來源‎: J Pediatr Hematol Oncol 2017;39(5):e259-62.

檢索‎: PubMed 28562517

DOI碼‎: 10.1097/MPH.0000000000000879

https://www.ncbi.nlm.nih.gov/pubmed/28562517 （開啟新視窗）

Advances in Pediatric Intravenous Iron Therapy. （開啟新視窗）

Mantadakis E.

來源‎: Pediatr Blood Cancer 2016;63(1):11-6.

檢索‎: PubMed 26376214

DOI碼‎: 10.1002/pbc.25752

https://www.ncbi.nlm.nih.gov/pubmed/26376214 （開啟新視窗）

The role of iron in the management of chemotherapy-induced anemia in cancer patients receiving erythropoiesis-stimulating agents. （開啟新視窗）

Mhaskar R, Wao H, Miladinovic B, Kumar A, Djulbegovic B.

來源‎: Cochrane Database Syst Rev 2016;(2):CD009624.

檢索‎: PubMed 26845108

DOI碼‎: 10.1002/14651858.CD009624.pub2

https://www.ncbi.nlm.nih.gov/pubmed/26845108 （開啟新視窗）

Randomized trial of intravenous iron supplementation in patients with chemotherapy-related anemia without iron deficiency treated with darbepoetin alpha. （開啟新視窗）

Pedrazzoli P, Farris A, Del Prete S, Del Gaizo F, Ferrari D, Bianchessi C, Colucci G, Desogus A, Gamucci T, Pappalardo A, Fornarini G, Pozzi P, Fabi A, Labianca R, Di Costanzo F, Secondino S, Crucitta E, Apolloni F, Del Santo A, Siena S.

來源‎: J Clin Oncol 2008;26(10):1619-25.

檢索‎: PubMed 18375891

DOI碼‎: 10.1200/JCO.2007.12.2051

https://www.ncbi.nlm.nih.gov/pubmed/18375891 （開啟新視窗）

Intravenous low molecular weight iron dextran in children with iron deficiency anemia unresponsive to oral iron. （開啟新視窗）

Plummer ES, Crary SE, McCavit TL, Buchanan GR

來源‎: Pediatr Blood Cancer 2013;60(11):1747-52.

檢索‎: PubMed 23832487

DOI碼‎: 10.1002/pbc.24676

https://www.ncbi.nlm.nih.gov/pubmed/23832487 （開啟新視窗）